Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
Vertex's pain prospect underwhelms versus placebo, sinking stock
The trial linked the molecule to a significant improvement from baseline, but placebo performed similarly, triggering a 12% drop in Vertex’s share.
Nick Paul Taylor
Dec 19, 2024 7:41am
Novo Holdings-backed SiteOne charges up with $100M financing
Dec 18, 2024 7:00am
CervoMed's ex-Vertex drug fails to reduce dementia symptoms
Dec 10, 2024 8:20am
Undaunted Vertex closes in on FDA nod for non-opioid pain drug
Oct 28, 2024 5:00am
Rectify drug repairs bile composition in mice with liver disease
Oct 22, 2024 7:00am
Vertex pain data: Combo results, Vicodin miss and stellar safety
Oct 21, 2024 9:55am
